To know the effect of magnesium sulphate on propofol requirement in abdominal surgeries under general anaesthesia
Phase 4
Completed
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2020/11/029315
- Lead Sponsor
- Department of AnaesthesiaGGSMCH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Age group between 18-65 years of either gender,giving valid consent
ASA grade I and II
Patients scheduled to undergo elective abdominal surgery under general anesthesia
Exclusion Criteria
�BMI >30
�Known allergy to magnesium and other study drugs
�Any renal, hepatic or cardiovascular dysfunction, atrioventricular block, neurological disorders
�Pregnancy
�Patients receiving long term beta blockers, calcium channel blockers, opioids, or magnesium.
�Anticipated difficult airway
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method �To calculate total propofol requirement with magnesium sulphate infusion in abdominal surgeries under general anaesthesia. <br/ ><br>�To calculate total propofol requirement without magnesium sulphate infusion in abdominal surgeries under general anaesthesia. <br/ ><br>Timepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method �To compare total propofol requirement with or without magnesium sulphate infusion in abdominal surgeries under general anaesthesia.Timepoint: within 30 minutes post operatively